Re: early relapses after the first dose of natalizumab in active multiple sclerosis

Mult Scler. 2009 Apr;15(4):520. doi: 10.1177/1352458508100036.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Humans
  • Multiple Sclerosis / drug therapy*
  • Natalizumab
  • Recurrence

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Natalizumab